Ethical Compliance
TORRENT PHARMACEUTICALS L
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
0.3%
Debt
26.1%
Liquidity
5.6%
Revenue
Debt
Liquidity
0.3%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
Other operating revenue | ₹165.53 |
other income | ₹28.44 |
pharma products | ₹10,562.31 |
Questionable
INR Crores
Non Compliant
INR Crores
interest & other | ₹29.47 |
INR Crores
Revenue from Questionable Sources: | ₹0.00 |
Revenue from Non Compliant Sources: | ₹29.47 |
Total: | ₹29.47 |
Total Revenue: | ₹10,785.75 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹29.47
₹10,785.75
= 0.3%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.